Intended use:
For in vitro diagnostic use. The RIDA®UNITY CAP Bac Test, performed automatically or manually, is a multiplex real-time PCR for the direct qualitative detection and differentiation of:
– Chlamydophila pneumoniae DNA
– Legionella pneumophila DNA
– Mycoplasma pneumoniae DNA
in human bronchoalveolar lavage (BAL) or nasal/throat swabs from individuals with signs and symptoms of community-acquired pneumonia (CAP).
The RIDA®UNITY CAP Bac Test is intended to support the differential diagnosis of infection with Chlamydophila pneumoniae, Legionella pneumophila, and Mycoplasma pneumoniae in patients with symptoms of community-acquired pneumonia in conjunction with other clinical and laboratory findings.
Negative results do not rule out infection with Chlamydophila pneumoniae, Legionella pneumophila, and Mycoplasma pneumoniae and should not be used as the sole basis for diagnosis.
The product is intended for professional use.
Accessories:
| Art. No. | UN2705 |
|---|---|
| Test format | real-time PCR with 96 reactions |
Dear customers,
we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal eifu.r-biopharm.com/IVD.
